A feasibility study of Multimodal Exercise/Nutrition/Anti-inflammatory treatment for Cachexia - the pre-MENAC study.

Phase 1

Active, not recruiting

• Conditions: lung cancer; MedDRA version: 16.0Level: LLTClassification code 10025044Term: Lung cancerSystem Organ Class: 100000004864; Therapeutic area: Diseases [C] - Cancer [C04]

• Registration Number: EUCTR2010-022897-14-DK
• Lead Sponsor: St. Olavs University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-05-08
• Last Update Posted: 20 June 2016

Recruitment & Eligibility

• Status: Not Recruiting
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

Lung cancer
Have a staging CT within 4 weeks of commencement of chemotherapy or chemoradiotherapy (in patients where staging CT is outwith this period, further CT scanning will be undertaken. PET-CTs are also appropriate)
18–75years of age
about to start chemotherapy
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 10
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 2

Exclusion Criteria

Renal impairment (serum albumin < 25 g/L or Child-Pugh =10 (pancreatic cancer patients only)), creatinine clearance <30ml/min (estimated using cockroft-gault, creatinine measured within two months of date of consent)
Patients who are taking either aspirin, NSAID or Cox 2 inhibitors prior to study entry
Women during pregnancy, breastfeeding or who are of child-bearing potential (that is not postmenopausal or permanently sterilised) age and who do not use adequate contraception (oral, injected or implanted or hormonal methods of contraception’s, intrauterine device and barrier method)

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified